Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on August 10, 2020. The filing serves to announce the Company's financial results for the period ended June 30, 2020, and provides an update on recent corporate events. The detailed results are contained in a press release and a letter to stockholders furnished as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing indicates an update on recent corporate events alongside the financial results for the period ended June 30, 2020. Specific details regarding material changes versus prior periods are not present in the main body of this report.
Guidance, Outlook, and Risks
The Company explicitly states that the information furnished under Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section. Furthermore, the Company does not assume any obligation to update the information or exhibits in the future. The filing does not contain specific forward-looking guidance or risk factors within the text provided.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue and earnings figures for the period ended June 30, 2020.
- Review Exhibit 99.2 (Letter to Stockholders) for details on the "recent corporate events" mentioned in the filing.
- Verify the Company's liquidity position and debt levels, as these are not disclosed in the summary text.
- Note that the Company has disclaimed an obligation to update the information provided in this 8-K.